Image pharmaphorum Editor Views & Analysis Artificial Intelligence for better antibody drugs: ready for... The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. Views & Analysis Capturing progress in haemophilia care If we look back just 70 years, the prognosis for patients with haemophilia was remarkably different to what it is today. Sales & Marketing Sponsored Unlocking the full power of data for Pharma The value of data has never been greater in healthcare. Patients Endometriosis: hidden suffering and disease burden Improving patient outcomes starts by listening to and understanding their needs. Load more results
Views & Analysis Artificial Intelligence for better antibody drugs: ready for... The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion.
Views & Analysis Capturing progress in haemophilia care If we look back just 70 years, the prognosis for patients with haemophilia was remarkably different to what it is today.
Sales & Marketing Sponsored Unlocking the full power of data for Pharma The value of data has never been greater in healthcare.
Patients Endometriosis: hidden suffering and disease burden Improving patient outcomes starts by listening to and understanding their needs.
News Europe is facing a surge in STIs, says ECDC Cases of sexually-transmitted infections (STIs) – particularly gonorrhoea and syphilis – are at record levels across 29 European countries.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
